a public good project by the
Synthesis
Company
of California

© 2026

Valerie W. Rusch | doi.page

0 works0 citations0 h-index

Valerie W. Rusch

Memorial Sloan Kettering Cancer Center(US)

Publications by Year

Research Areas

Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Occupational and environmental lung diseases, Pleural and Pulmonary Diseases, Medical Imaging and Pathology Studies

Most-Cited Works

→ International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma(2011)4,802 cited
→ The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer(2016)4,558 cited
→ EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib(2004)4,332 cited
→ The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours(2007)3,668 cited
→ CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment(2003)2,561 cited
→

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

(2018)

2,099 cited

→ MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib(2007)1,584 cited

→ Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial(2009)1,460 cited

→ Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study(2008)1,237 cited

→ The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer(2009)1,185 cited